2021

1. Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after transcatheter aortic valve replacement
   European Heart Journal - Cardiovascular Imaging. 2021 Sep 00:1-9
2. Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
   JACC: Cardiovascular Interventions. 2021 Dec 14(24):2670-2681
3. Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease
   The American Journal of Cardiology. 2021 Dec; 160:21-30
4. Long-Term Clinical Impact of Intravascular Ultrasound Guidance in Stenting for Left Main Coronary Artery Disease
   Circulation: Cardiovascular Interventions. 2021 Oct;14(10):1012-1021
5. Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention
   JACC: Cardiovascular Interventions. 2021 sep 14(18):2059-2068
6. Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease
   Catheterization and Cardiovascular Interventions. 2021 Nov;98(5):E705-E714.
7. Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation
   The American Journal of Cardiology. 2021 Aug 152:99-105
8. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study
   Journal of the american heart association. 2021 Jul;10(14)
9. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial
   Journal of the American Heart Association. 2021 Jul ;10(14):e020359
10. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement
    BMJ Open 2021 Feb 11(1):
11. Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation
    The American Journal of Cardiology. 2021 Jan 139; 79-86
12. Prevalence, predictors, prognostic significance, and effect of techniques on outcomes of coronary lesion calcification following implantation of drug-eluting stents: a patient-level pooled analysis of stent-specific, multicenter, prospective IRIS-DES registries
    Coronary Artery Disease 2021 Jan, 32(1):42-50

2020

1. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction
   Journal of the American College of Cardiology. 2020 Sep 76(12):1395-1406
2. Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions
   Catheter Cardiovasc Interv. 2020 Sep;97(5):776-785.
3. Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings
   The American Journal of Cardiology. 2020 Jun 125(11):1624-1630
4. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial
   Circulation. 2020 May 141(18) 1437-1446.
5. Rates and Independent Correlates of 10-Year Major Adverse Events and Mortality in Patients Undergoing Left Main Coronary Arterial Revascularization
   The American Journal of Cardiology. 2020 Apr 125(8):1148-1153.
6. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease
   JACC: Cardiovascular Interventions. 2020 Feb 13(3):361-371.
7. Nutritional status and risk of all-cause mortality in patients undergoing transcatheter aortic valve replacement assessment using the geriatric nutritional risk index and the controlling nutritional status score
   Clinical Research in Cardiology. 2020 Feb 109(2):161-171.

2019

1. Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease
   American Heart Journal. 2019 Dec;218:9-19
2. Clinical outcomes of contemporary drug-eluting stents in patients with and without diabetes mellitus: Multigroup propensity-score analysis using data from stent-specific, multicenter, prospective registries
   Catheter Cardiovasc Interv. 2019 Sep 3 ;1-10
3. Effect of Age and Sex on Outcomes After Stenting or Bypass Surgery in Left Main Coronary Artery Disease
   The American Journal of Cardiology. 2019 Sep 1;124(5):678-687.
4. Comparative effectiveness of different contemporary drug-eluting stents in routine clinical practice: a multigroup propensity score analysis using data from the stent-specific, multicenter, prospective registries
   Coronary artery disease. 2019 Jun;30(4):255-262.
5. Differential cutoff points and clinical impact of stent parameters of various drug-eluting stents for predicting major adverse clinical events: An individual patient data pooled analysis of seven stent-specific registries and 17,068 patients
   International Journal of Cardiology. 2019 May 1;282:17-23.
6. Incidence, Predictors, Management, and Clinical Significance of New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation
   The American Journal of Cardiology. 2019 Apr 1;123(7):1127-1133.
7. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial
   Circulation. 2019 Apr 2;139(14):1674-1683.
8. Relation of Body Mass Index to Risk of Death or Stroke in Patients Who Underwent Transcatheter Aortic Valve Implantation.
   The American Journal of Cardiology. 2019 Feb 15;123(4):638-643.
9. Temporal changes in characteristics, treatment strategies, and outcomes of coronary bifurcation lesion interventions
   Coronary artery disease. 2019 Jan;30(1):33-43.
10. Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial.
    Coronary artery disease. 2019 Jan;30(1):59-66.

2018

1. Temporal changes in characteristics, treatment strategies, and outcomes of coronary bifurcation lesion interventions
   Coronary artery disease (2019) 30:33-43
2. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea
   The Korean Journal of Internal Medicine (2018) 33:922-932
3. Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
   Journal of the American College of Cardiology (2018) 72:2813-2822
4. Impact of Coronary Lesion Geometry on Fractional Flow Reserve: Data From Interventional Cardiology Research In-Cooperation Society-Fractional Flow Reserve and Intravascular Ultrasound Registry
   Circulation: Cardiovascular imaging (2018) 11:1-8
5. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial
   Journal of the American College of Cardiology (2018) 71:2335-2342
6. Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRIS-FFR registry
   European Heart Journal (2018) 39:1610-1619
7. Effect of Low-Dose Ticagrelor versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes
   Journal of the American College of Cardiology (2018) 71:1594-1595
8. Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery Disease
   Journal of the American College of Cardiology (2018) 71:832-841
9. Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial
   American Heart Journal (2018) 197:35-42
10. Comparison of 1-Year Outcomes of Triple (Aspirin+Clopidogrel+Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin+Clopidogrel+Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial
    The American Journal of Cardiology (2018) 121:423-429
11. Sex differences in left main coronary artery stenting: Different characteristics but similar outcomes for women compared with men
    International Journal of Cardiology (2018) 253:50-54
12. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies
    Circulation : Cardiovascular Interventions (2018) 11:1-12

2017

1. Impact of left main coronary artery disease on long-term mortality in patients undergoing drug-eluting stent implantation
   Clin Res Cardiol (2017) 106:953-959
2. Fractional flow reserve and pressure-bounded coronary flow reserve to predict outcomes in coronary artery disease
   European Heart Journal (2017) 38, 1980-1989
3. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents
   JACC. Cardiovascular Interventions. 2017 Jun 12;10(11):1075-1085.
4. Coronary artery bypass graft surgery versus drug-eluting stent implantation for high surgical-risk patients with left main ormultivessel coronary artery disease
   European Journal of Cardio-Thoracic Surgery 51 (2017) 943-949
5. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease
   Circulation. 2017 Jun 6;135(23):2241-2251.
6. Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug-Eluting Stents in Older Adults
   Journal of the American Geriatrics Society. 2017 Mar;65(3):625-630.
7. Benefit of Final Kissing Balloon Inflation Mandatory After Simple Crossover Stenting for Left Main Bifurcation Narrowing
   The American Journal of Cardiology. 2017 Feb 15;119(4):528-534.
8. Impact of Multivessel Coronary Artery Disease With Versus Without Left Main Coronary Artery Disease on Long-Term Mortality After Coronary Bypass Grafting Versus Drug-Eluting Stent Implantation
   The American Journal of Cardiology. 2017 Jan 15;119(2):225-230.
9. Predictors of Long-Term Outcomes after Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease
   Catheterization and Cardiovascular Interventions 90:177-185 (2017)
10. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy
    Circulation. Cardiovascular imaging. 2017 Jul;10(7). pii: e005934.
11. Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease
    Coronary artery disease. 2017 Aug;28(5):387-394.
12. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease
    JACC. Cardiovascular Interventions. 2017 Jul 24;10(14):1415-1424.
13. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication Insights From a Large International Multicenter Registry
    Circulation. Cardiovascular Interventions. 2017 Jul;10(7). .
14. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for NoneST-Elevation Acute Coronary Syndrome
    The American Journal of Cardiology. 2017 Aug 1;120(3):380-386.
15. Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease
    Coronary Artery Disease. 2017 Dec;28(8):675-682
16. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions
    JACC. Cardiovascular Interventions. 2017 Aug 14;10(15):1498-1507.
17. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.
    The Korean Journal of Internal Medicine. 2017 Nov 7.
18. Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry
    American Heart Journal. 2017 Nov;193:76-83.

2016

1. Predictors for Paravalvular Regurgitation After TAVR With the Self-Expanding Prosthesis: Quantitative Measurement of MDCT Analysis.
   JACC. Cardiovascular imaging. 2016 Oct;9(10):1233-1234.
2. Temporal Changes in Outcomes After Stenting or Bypass Surgery for Unprotected Left Main Coronary Artery Disease According to Diabetes Status.
   JACC. Cardiovascular Interventions. 2016 Dec 26;9(24):2575-2578.
3. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
   JACC. Cardiovascular Interventions. 2016 Dec 26;9(24):2481-2489.
4. Benefit of Final Kissing Balloon Inflation Mandatory After Simple Crossover Stenting for Left Main Bifurcation Narrowing
   The American Journal of Cardiology. 2016 Nov 16.
5. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents
   American Heart Journal. 2016 Sep;179:157-65.
6. Left Main Coronary Artery Disease Secular Trends in Patient Characteristics, Treatments, and Outcomes
   Journal of the American College of Cardiology. 2016 Sep 13;68(11):1233-46.
7. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population
   JACC. Cardiovascular Interventions. 2016May;9(9):926-933.
8. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease
   Journal of the American College of Cardiology. 2016 Jul 5;68(1):29-36.
9. Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction
   The American Journal of Cardiology. 2016 Jul 1;118(1):17-22. .
10. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study
    Journal of the American College of Cardiology. 2016April;67(15):1772-1783 .

2015

1. Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
   The New England Journal of Medicine. 2015 Mar 26;372(13):1204-12.
2. Temporal Patterns of Drug-Eluting Stent Failure and Its Relationship with Clinical Outcomes
   Catheterization and Cardiovascular Interventions. 2015 Mar;85(4):515-21.
3. Temporal Trends in Revascularization Strategy and Outcomes in Left Main Coronary Artery Stenosis: Data from the Asan Medical Center-Left Main Revascularization Registry
   Circulation. Cardiovascular Interventions. 2015 Mar;8(3).
4. Impact of In-Hospital Bleeding According to the Bleeding Academic Research Consortium Classification on the Long-Term Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention
   Catheterization and Cardiovascular Interventions. 2015 Jan 1;85(1):63-71.
5. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
   Journal of the American College of Cardiology. 2015 May 26;65(20):2198-206.
6. Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three Vessel Disease with the Routine Incorporation of Fractional Flow Reserve in Real Practice
   The American Journal of Cardiology. Oct 15;116(8):1163-71.
7. Comparison of Aortic Root Anatomy and Calcification Distribution Between Asian and Caucasian Patients Who Underwent Transcatheter Aortic Valve Implantation
   The American Journal of Cardiology. 2015 Nov 15;116(10):1566-73.
8. Long-Term Clinical Outcomes of Mechanical versus Bioprosthetic Aortic Valve Replacement in Older Patients
   Asiaintervention. 2015;1:72-80.

2014

1. Functional and Morphological Assessment of Side Branch After Left Main Coronary Artery Bifurcation Stenting with Cross-Over Technique
   Catheterization and Cardiovascular Interventions. 2014 Mar 1;83(4):545-52.
2. Differences in Intravascular Ultrasound and Histological Findings in Culprit Coronary Plaques Between ST-Segment Elevation Myocardial Infarction and Stable Angina
   Journal of thrombosis and thrombolysis. 2014 May;37(4):443-9.
3. Impact of the Angiographic Mechanisms Underlying Periprocedural Myocardial Infarction After Drug-Eluting Stent Implantation
   The American Journal of Cardiology. 2014 Apr 1;113(7):1105-10.
4. Edge Dissection of Calcified Plaque as a Possible Mechanism for Acute Coronary Syndrome
   Journal of thrombosis and thrombolysis. 2014 Nov;38(4):503-9.
5. Readmission Rate After Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Narrowing
   The American Journal of Cardiology. 2014 May 15;113(10):1639-46.
6. Meta-Analysis of Outcomes After Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Eluting Stent Implantation in 26,503 Patients Enrolled in Three Randomized Trials and 14 Observational Studies
   The American Journal of Cardiology. 2014 Apr 15;113(8):1338-47.
7. Sex Difference in Clinical Outcomes After Percutaneous Coronary Intervention in Korean Population
   American Heart Journal. 2014 May;167(5):743-52.
8. Comparison of Biolimus A9-Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions: A Randomized Long Drug-Eluting Stent V Trial
   Circulation. Cardiovascular Interventions. 2014 Jun;7(3):322-9.
9. Drug-Eluting Stents for ST-Elevation Myocardial Infarction: Ready for Prime Time?
   Coronary artery disease. 2014 Aug;25(5):365-6.
10. Intravascular Ultrasound-Derived Minimal Lumen Area Criteria for Functionally Significant Left Main Coronary Artery Stenosis
    JACC. Cardiovascular Interventions. 2014 Aug;7(8):868-74.
11. "Full Metal Jacket" Drug-Eluting Stent Implantation: a Reasonable Therapeutic Option for Advanced Coronary Artery Disease?
    Catheterization and Cardiovascular Interventions. 2014 Dec 1;84(7):1051-2.
12. Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized Controlled Trial
    Circulation. 2014 Jan 21;129(3):304-12.
13. Multimodality Imaging of Attenuated Plaque Using Grayscale and Virtual Histology Intravascular Ultrasound and Optical Coherent Tomography
    Catheterization and Cardiovascular Interventions. 2014 Dec 15.

2013

1. Trends in the Outcomes of Percutaneous Coronary Intervention with the Routine Incorporation of Fractional Flow Reserve in Real Practice
   European Heart Journal. 2013 Nov;34(43):3353-61.
2. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in a Real World Population
   Catheterization and Cardiovascular Interventions. 2013 Feb;81(3):407-16.
3. Differential Prognostic Effect of Intravascular Ultrasound Use According to Implanted Stent Length
   The American Journal of Cardiology. 2013 Mar 15;111(6):829-35.
4. Frequency, Causes, Predictors, and Clinical Significance of Peri-Procedural Myocardial Infarction Following Percutaneous Coronary Intervention
   European Heart Journal. 2013 Jun;34(22):1662-9.
5. Intravascular Ultrasound Assessment of Drug-Eluting Stent Coverage of the Coronary Ostium and Effect on Outcomes
   The American Journal of Cardiology. 2013 May 15;111(10):1401-7.
6. Intravascular Ultrasound Predictors for Edge Restenosis After Newer Generation Drug-Eluting Stent Implantation
   The American Journal of Cardiology. 2013 May 15;111(10):1408-14.
7. Statins for Treating Stable Angina: Can Statins Improve the Plaque Morphology and Angina?
   Future Cardiology. 2013 Mar;9(2):155-8.
8. Association of Body Mass Index With Major Cardiovascular Events and With Mortality After Percutaneous Coronary Intervention
   Circulation. Cardiovascular Interventions. 2013 Apr 1;6(2):146-53.
9. OCT Analysis in Patients with Very Late Stent Thrombosis
   JACC. Cardiovascular imaging. 2013 Jun;6(6):695-703.
10. Hemodynamic Impact of Changes in Bifurcation Geometry After Single-Stent Cross-Over Technique Assessed by Intravascular Ultrasound and Fractional Flow Reserve
    Catheterization and Cardiovascular Interventions. 2013 Dec 1;82(7):1075-82.
11. Differential Long-Term Outcomes of Zotarolimus-Eluting Stents Compared with Sirolimus-Eluting and Paclitaxel-Eluting Stents in Diabetic and Nondiabetic Patients: Two-Year Subgroup Analysis of the ZEST Randomized Trial
    Catheterization and Cardiovascular Interventions. 2013 Jun 1;81(7):1106-14.
12. Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus from the ESSENCE-DIABETES II Trial
    The American Journal of Cardiology. 2013 Nov 15;112(10):1565-70.
13. Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials)
    The American Journal of Cardiology. 2013 Dec 1;112(11):1738-44.
14. Predictors for Functionally Significant In-Stent Restenosis: An Integrated Analysis Using Coronary Angiography, IVUS, and Myocardial Perfusion Imaging
    JACC. Cardiovascular imaging. 2013 Nov;6(11):1183-90.
15. Prevalence and Clinical Implications of Newly Revealed, Asymptomatic Abnormal Ankle-Brachial Index in Patients with Significant Coronary Artery Disease
    JACC. Cardiovascular Interventions. 2013 Dec;6(12):1303-13.
16. Long-Term Luminal Change After Drug-Eluting Stent Implantation; Serial Angiographic Follow-Up Study of the Zest Randomized Trial
    Catheterization and Cardiovascular Interventions. 2013 Feb;81(2):274-82.
17. Differential Prognostic Impact of High On-Treatment Platelet Reactivity Among Patients with Acute Coronary Syndromes Versus Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    American Heart Journal. 2013 Jan;165(1):34-42.

2012

1. Impact of Ischemia-Guided Revascularization with Myocardial Perfusion Imaging for Patients with Multivessel Coronary Disease
   Journal of the American College of Cardiology. 2012 Jul 17;60(3):181-90.
2. Comparison of the Efficacy and Safety of Paclitaxel-Eluting Coroflex Please Stents and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease: A Randomized PIPA Trial
   Catheterization and Cardiovascular Interventions. 2012 Nov 1;80(5):799-806.
3. Comparative Long-Term Efficacy and Safety of Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Ostial Left Main Coronary Artery Disease: Analysis of the MAIN-COMPARE Registry
   Catheterization and Cardiovascular Interventions. 2012 Aug 1;80(2):206-12.
4. Comparison of Effects of Atorvastatin (20 mg) Versus Rosuvastatin (10 mg) Therapy on Mild Coronary Atherosclerotic Plaques (from the ARTMAP Trial)
   The American Journal of Cardiology. 2012 Jun 15;109(12):1700-4.
5. Influence of Diabetes Mellitus on Long-Term (Five-Year) Outcomes of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization
   The American Journal of Cardiology. 2012 Jun 1;109(11):1548-57.
6. Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After Drug-Eluting Stent Implantation
   Journal of the American College of Cardiology. 2012 Mar 20;59(12):1093-100.
7. Outcomes After Unrestricted Use of Everolimus-Eluting and Sirolimus-Eluting Stents in Routine Clinical Practice: A Multicenter, Prospective Cohort Study
   Circulation. Cardiovascular Interventions. 2012 Jun 1;5(3):365-371.
8. Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis: The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) Study
   JACC. Cardiovascular Interventions. 2012 Jul;5(7):708-17.
9. Long-Term Outcome of Stents Versus Bypass Surgery in Diabetic and Nondiabetic Patients With Multivessel or Left Main Coronary Artery Disease: A Pooled Analysis of 5775 Individual Patient Data
   Circulation. Cardiovascular Interventions. 2012 Aug 1;5(4):467-75.
10. Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions: A Randomized LONG-DES IV Trial
    Circulation. Cardiovascular Interventions. 2012 Oct 1;5(5):633-40.
11. Validation of Functional State of Coronary Tandem Lesions Using Computational Flow Dynamics
    The American Journal of Cardiology. 2012 Dec 1;110(11):1578-84.
12. Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve
    JACC. Cardiovascular Interventions. 2012 Oct;5(10):1029-36.
13. Should We Be Using Fractional Flow Reserve More Routinely to Select Stable Coronary Patients for Percutaneous Coronary Intervention?
    Current opinion in Cardiology. 2012 Nov;27(6):675-81.
14. Unprotected Left Main Percutaneous Coronary Intervention: Integrated Use of Fractional Flow Reserve and Intravascular Ultrasound
    Journal of the American Heart Association. 2012 Dec;1(6). Epub 2012 Dec 19.
15. Acute and Long-Term Angiographic Outcomes of Side Branch Stenosis After Randomized Treatment of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stent for Coronary Artery Stenosis
    Journal of Korean Medical science. 2012 Dec;27(12):1499-506.
16. Expression of ADAMTS-2, -3, -13, and -14 in Culprit Coronary Lesions in Patients with Acute Myocardial Infarction or Stable Angina
    Journal of thrombosis and thrombolysis. 2012 May;33(4):362-70.

2011

1. Expression of HMG-CoA Reductase in Human Coronary Atherosclerotic Plaques and Relationship to Plaque Destabilisation
   Heart. 2011 May;97(9):715-20.
2. Effect of Intravascular Ultrasound Findings on Long-Term Repeat Revascularization in Patients Undergoing Drug-Eluting Stent Implantation for Severe Unprotected Left Main Bifurcation Narrowing
   The American Journal of Cardiology. 2011 Feb 1;107(3):367-73.
3. Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization: 5-Year Outcomes from the Asan Medical Center-Multivessel Evascularization Registry
   Journal of the American College of Cardiology. 2011 Jan 11;57(2):128-37.
4. Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation: Intravascular Ultrasound Analysis
   Circulation. Cardiovascular Interventions. 2011 Feb 1;4(1):9-14.
5. Validation of Intravascular Ultrasound-Derived Parameters with Fractional Flow Reserve for Assessment of Coronary Stenosis Severity
   Circulation. Cardiovascular Interventions. 2011 Feb 1;4(1):65-71.
6. Comparison of Single- Versus Two-stent Techniques in Treatment of Unprotected Left Main Coronary Bifurcation Disease
   Catheterization and Cardiovascular Interventions. 2011 Apr;1:77:775-782.
7. Incidence, Predictors, Treatment, and Long-Term Prognosis of Patients with Restenosis After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease
   Journal of the American College of Cardiology. 2011 Mar 22;57(12):1349-58.
8. Comparison of Dual Drug-Eluting Cilotax Stent and Paclitaxel-Eluting Taxus Liberte Stent in Native Coronary Artery Lesions
   The American Journal of Cardiology. 2011 Apr 1;107(7):990-4.
9. Hospital Discharge Risk Score System for the Assessment of Clinical Outcomes in Patients with Acute Myocardial Infarction (Korea Acute Myocardial Infarction Registry [KAMIR] Score)
   The American Journal of Cardiology. 2011 Apr 1;107(7):965-971.e1.
10. Sirolimus- Versus Paclitaxel-Eluting Stents for Unselected Patients with Coronary Artery Disease
    Catheterization and Cardiovascular Interventions. 2011 Jan 1;77(1):13-4.
11. Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents: Intimal Hyperplasia and Vascular Changes Assessed by Volumetric Intravascular ltrasound Analysis
    Circulation. Cardiovascular Interventions. 2011 Apr 1;4(2):139-45.
12. Comparison of ADAMTS-1, -4 and -5 Expression in Culprit Plaques Between Acute Myocardial Infarction and Stable Angina
    Journal of Clinical Pathology. 2011 May;64(5):399-404.
13. Prediction of Outcomes After Percutanesous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis Using the EuroSCORE
    Catheterization and Cardiovascular Interventions. 2011 Apr 1;77(5):633.
14. Left Main Stenting
    Circulation. 2011 Apr;75(4):749-55.
15. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease
    The New England Journal of Medicine. 2011 May 5;364(18):1718-27.
16. Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease
    Circulation. 2011;123:2373-2381.
17. Impact of Bleeding on Subsequent Early and Late Mortality After Drug-Eluting Stent Implantation
    JACC. Cardiovascular Interventions. 2011 Apr;4(4):423-31.
18. Preintervention Angiographic and Intravascular Ultrasound Predictors for Side Branch Compromise After a Single-Stent Crossover Technique
    The American Journal of Cardiology. 2011 Jun 15;107(12):1787-93.
19. Long-Term Clinical Outcomes of Successful Versus Unsuccessful Revascularization with Drug-Eluting Stents for True Chronic Total Occlusion
    Catheterization and Cardiovascular Interventions. 2011 Sep 1;78(3):346-53.
20. A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients with Diabetes Mellitus: 4-Year Clinical Outcomes of DES-DIABETES (Drug-Eluting Stent in Patients with DIABETES Mellitus) Trial
    JACC. Cardiovascular Interventions. 2011 Mar;4(3):310-6.
21. Preventive Strategies of Renal Insufficiency in Patients With Diabetes Undergoing Intervention or Arteriography (the PREVENT Trial)
    The American Journal of Cardiology. 2011 May 15;107(10):1447-52.
22. Comparison of Ruptured Coronary Plaques in Patients with Unstable and Stable Clinical Presentation
    Journal of thrombosis and thrombolysis. 2011 Aug;32(2):150-7.
23. Complexity of Atherosclerotic Coronary Artery Disease and Long-Term Outcomes in Patients with Unprotected Left Main Disease Treated with Drug-Eluting Stents or Coronary Artery Bypass Grafting
    Journal of the American College of Cardiology. 2011 May 24;57(21):2152-9.
24. Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug-Eluting Stent Implantation
    Circulation. 2011;123:2954-2963.
25. Validation of Minimal Luminal Area Measured by Intravascular Ultrasound for Assessment of Functionally Significant Coronary Stenosis Comparison with Myocardial Perfusion Imaging
    JACC. Cardiovascular Interventions. 2011 Jun;4(6):665-71.
26. Changes in Left Main Bifurcation Geometry After a Single-Stent Crossover Technique: An Intravascular Ultrasound Study Using Direct Imaging of Both the Left Anterior Descending and the Left Circumflex Coronary Arteries Before and After Intervention
    Circulation. Cardiovascular Interventions. 2011 Aug 1;4(4):355-61.
27. Nonrandomized Data on Drug-Eluting Stents Compared with Coronary Bypass Surgery Caution with Interpretation Reply
    Journal of the American College of Cardiology. 2011 Jun;57(24):2458-9.
28. Comparison of Differential Expression of P2Y(12) Receptor in Culprit Coronary Plaques in Patients with Acute Myocardial Infarction Versus Stable Angina Pectoris
    The American Journal of Cardiology. 2011 Sep 15;108(6):799-803.
29. Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients with Diabetes Mellitus (ESSENCE-DIABETES): results From the ESSENCE-DIABETES Trial
    Circulation. 2011 Aug 23;124(8):886-892.
30. Procedure-Induced Acute Common Carotid Artery Perforation Presenting with Airway Obstruction and Successful Treatment by Endovascular Stent Graft
    Korean Circulation Journal. 2011 Jul;41(7):405-8.
31. Paradigm Shift to Functional Angioplasty: New Insights for Fractional Flow Reserve- and Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
    Circulation. 2011 Aug 23;124(8):951-7.
32. TCTAP 2011: Connecting East and West for Interventional Societies
    Expert review of Cardiovascular Therapy. 2011 Aug;9(8):983-5.
33. Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients with Long Coronary Artery Lesions a Randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III) Trial
    JACC. Cardiovascular Interventions. 2011 Oct;4(10):1096-103.
34. Comprehensive Intravascular Ultrasound Assessment of Stent Area and Its Impact on Restenosis and Adverse Cardiac Events in 403 Patients with Unprotected Left Main Disease
    Circulation. Cardiovascular Interventions. 2011 Dec 1;4(6):562-9.
35. Intravascular Ultrasound-Derived Predictors for Fractional Flow Reserve in Intermediate Left Main Disease
    JACC. Cardiovascular Interventions. 2011 Nov;4(11):1168-74.
36. A Point-of-Care Platelet Function Assay and C-Reactive Protein for Prediction of Major Cardiovascular Events After Drug-Eluting Stent Implantation
    Journal of the American College of Cardiology. 2011 Dec 13;58(25):2630-9.
37. Impact of Plaque Components on No-Reflow Phenomenon After Stent Deployment in Patients with Acute Coronary Syndrome: a Virtual Histology-Intravascular Ultrasound Analysis
    European Heart Journal. 2011 Aug;32(16):2059-66.

2010

1. Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
   The New England Journal of Medicine. 2010 Apr 15;362(15):1374-82.
2. Comparison of Zotarolimus-Eluting Stents with Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization: the ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and Paclitaxel-Eluting Stent for Coronary Lesions) Randomized Trial
   Journal of the American College of Cardiology. 2010 Oct 5;56(15):1187-95.
3. Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry
   Journal of the American College of Cardiology. 2010 Oct 19;56(17):1366-75.
4. Serum B-type Natriuretic Peptide on Admission Can Predict the 'No-Reflow' Phenomenon After Primary Drug-Eluting Stent Implantation for ST-Segment Elevation Myocardial Infarction
   International Journal of Cardiology. 2010 May 28;141(2):175-81.
5. The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation
   JACC. Cardiovascular Interventions. 2010 Apr;3(4):383-9.
6. Validation of SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization
   JACC. Cardiovascular Interventions. 2010 Jun;3(6):612-23.
7. Triple Antiplatelet Therapy Reduces Ischemic Events After Drug-Eluting Stent Implantation: Drug-Eluting Stenting Followed by Cilostazol Treatment REduces Adverse Serious Cardiac Events (DECREASE registry)
   American Heart Journal. 2010 Feb;159(2):284-291.e1.
8. Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug-Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)
   The American Journal of Cardiology. 2010 Jan 15;105(2):168-73.
9. Effect of Renal Function on Ultrasonic Coronary Plaque Characteristics in Patients with Acute Myocardial Infarction
   The American Journal of Cardiology. 2010 Apr 1;105(7):936-42.
10. Long-term Outcomes of Intravascular Ultrasound-Guided Stenting in Coronary Bifurcation Lesions
    The American Journal of Cardiology. 2010 Sep1;106(5):612-8.
11. Two-Year Clinical Outcome After Abciximab-Coated Stent Implantation in Patients With Coronary Artery Disease
    Circulation. 2010 Mar;74(3):442-8.
12. Relation Between Plaque Components and Plaque Prolapse After Drug-Eluting Stent Implantation
    Circulation. 2010 Jun;74(6):1142-51.
13. Major Predictors of Long-term Clinical Outcomes After Coronary Revascularization in Patients with Unprotected Left Main Coronary Disease: Analysis from the MAIN-COMPARE Study
    Circulation. Cardiovascular Interventions. 2010 Apr;3(2):127-33.
14. Age-Related Differences in Virtual Histology-Intravascular Ultrasound Findings in Patients with Coronary Artery Disease
    Journal of Cardiology. 2010 Mar;55(2):224-31.
15. Differences in Intravascular Ultrasound Findings in Culprit Lesions in Infarct-Related Arteries Between ST Segment Elevation Myocardial Infarction and Non-ST Segment Elevation Myocardial Infarction
    Journal of Cardiology. 2010 Jul;56(1):15-22.
16. Effect of Contrast-Induced Nephropathy on Cardiac Outcomes After Use of Nonionic Isosmolar Contrast Media During Coronary Procedure
    Journal of Cardiology. 2010 Nov;56(3):300-6.

2009

1. Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients with Unprotected Left Main Coronary Artery Disease: Analysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry
   Journal of the American College of Cardiology. 2009 Aug 25;54(9):853-9.
2. Impact of Diabetes Mellitus on the Treatment Effect of Percutaneous or Surgical Revascularization for Patients With Unprotected Left Main Coronary Artery Disease
   JACC. Cardiovascular Interventions. 2009 Oct;2(10):956-63.
3. A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients with Diabetes Mellitus 2-Year Clinical Outcomes of the DES-DIABETES Trial
   Journal of the American College of Cardiology. 2009 Mar 3;53(9):812-3.
4. Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients with High Post-Treatment Platelet Reactivity
   Journal of the American College of Cardiology. 2009 Mar 31;53(13):1101-9.
5. The Beneficial Effect of High Loading Dose of Rosuvastatin Before Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
   International Journal of Cardiology. 2009 Nov 12;137(3):246-51.
6. Prognostic Influence of Diabetes Mellitus on Long-Term Clinical Outcomes and Stent Thrombosis After Drug-Eluting Stent Implantation in Asian Patients
   The American Journal of Cardiology. 2009 Mar 1;103(5):646-52.
7. Impact of Plaque Characteristics Analyzed by Intravascular Ultrasound on Long-Term Clinical Outcomes
   The American Journal of Cardiology. 2009 May 1;103(9):1221-6.
8. Comparison of the Efficacy and Safety of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents in Patients with ST-Elevation Myocardial Infarction
   The American Journal of Cardiology. 2009 Nov 15;104(10):1370-6.
9. Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis
   Circulation. Cardiovascular Interventions. 2009 Jun;2(3):167-77.
10. The Effect of Alpha Lipoic Acid in a Porcine In-Stent Restenosis Model
    Journal of Cardiology. 2009 Dec;54(3):375-85.
11. Clinical Outcomes and Optimal Treatment for Stent Fracture After Drug-Eluting Stent Implantation
    Journal of Cardiology. 2009 Jun;53(3):422-8.
12. C-Reactive Protein and The Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
    Circulation. 2009 Nov 17;120(20):1987-95.
13. Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting with Drug-Eluting Stents Compared with Bare-Metal Stents
    Circulation. 2009 Aug 4;120(5):400-7.
14. Incidence and Predictors of Drug-Eluting Stent Fractures in Long Coronary Disease
    International Journal of Cardiology. 2009 Apr 17;133(3):354-8.

2008

1. Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
   The New England Journal of Medicine. 2008 Apr 24;358(17):1781-92.
2. Long-Term Mortality After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease
   Circulation. 2008 Apr 22;117(16):2079-86.
3. Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Diabetes Mellitus
   Journal of the American College of Cardiology. 2008 Mar 25;51(12):1181-7.
4. A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients with Diabetes Mellitus
   Journal of the American College of Cardiology. 2008 Aug 26;52(9):727-33.
5. Safety and Effectiveness of Sirolimus-Eluting Stent Implantation for In-Stent Restenosis of the Unprotected Left Main Coronary Artery
   International Journal of Cardiology. 2008 Feb 20;124(1):118-20.
6. Impact of Significant Chronic Kidney Disease on Long-Term Clinical Outcomes After Drug-Eluting Stent Versus Bare Metal Stent Implantation
   International Journal of Cardiology. 2008 Mar 28;125(1):36-40.
7. Percutaneous Coronary Intervention with Stenting of Left Main Coronary Artery with Drug-Eluting Stent in the Setting of Acute ST Elevation Myocardial Infarction
   International Journal of Cardiology. 2008 May 23;126(2):224-8.
8. Impact of Periprocedural Myonecrosis on Clinical Events After Implantation of Drug-Eluting Stents
   International Journal of Cardiology. 2008 Oct 13;129(3):368-72.
9. A Three-Vessel Virtual Histology Intravascular Ultrasound Analysis of Frequency and Distribution of Thin-Cap Fibroatheromas in Patients with Acute Coronary Syndrome or Stable Angina Pectoris
   The American Journal of Cardiology. 2008 Mar 1;101(5):568-72.
10. Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients- CIilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) Trial
    Circulation. 2008 Jan;72(1):35-9.
11. Age-Related Differences in Intravascular Ultrasound Findings in 1,009 Coronary Artery Disease Patients
    Circulation. 2008 Aug;72(8):1270-5.
12. Long-Term Clinical Outcomes After Sirolimus-Eluting Stent Implantation for Treatment of Restenosis Within Bare-Metal Versus Drug-Eluting Stents
    Catheterization and Cardiovascular Interventions. 2008 Apr 1;71(5):594-8.
13. Late Target Lesion Revascularization After Implantation of Sirolimus-Eluting Stent
    Catheterization and Cardiovascular Interventions. 2008 Feb 15;71(3):299-303.

2007

1. Plaque Ruptures in Stable Angina Pectoris Compared with Acute Coronary Syndrome
   International Journal of Cardiology. 2007 Jan 2;114(1):78-82.
2. Five-Year Outcomes After Stenting of Unprotected Left Main Coronary Artery Stenosis in Patients with Normal Left Ventricular Function
   International Journal of Cardiology. 2007 Feb 7;115(2):208-13.
3. Comparison of Angiographic Patterns of In-Stent Restenosis Between Sirolimus- and Paclitaxel-Eluting Stent
   International Journal of Cardiology. 2007 Sep 3;120(3):387-90.
4. Impact of Postprocedure Minimum Stent Area on Long-Term Results Following Abciximab-Coated Stent Implantation; An Intravascular Ultrasound Analysis
   International Journal of Cardiology. 2007 Dec 15;123(1):23-8.
5. Prognostic Impact of Preprocedural C Reactive Protein Levels on 6-Month Angiographic and 1-Year Clinical Outcomes After Drug-Eluting Stent Implantation
   Heart. 2007 Sep;93(9):1087-92.
6. Serial Intravascular Ultrasound Evidence of Both Plaque Stabilization and Lesion Progression in Patients with Ruptured Coronary Plaques: Effects of Statin Therapy on Ruptured Coronary Plaque
   Atherosclerosis. 2007 Mar;191(1):107-14.
7. Frequency of Coronary Arterial Late Angiographic Stent Thrombosis (LAST) in the First Six Months: Outcomes with Drug-Eluting Stents Versus Bare Metal Stents
   The American Journal of Cardiology. 2007 Mar 15;99(6):774-8.
8. Results and Predictors of Angiographic Restenosis and Long-Term Adverse Cardiac Events After Drug-Eluting Stent Implantation for Aorto-Ostial Coronary Artery Disease
   The American Journal of Cardiology. 2007 Mar 15;99(6):760-5.
9. Usefulness of Serum N-Terminal Pro-Brain Natriuretic Peptide to Predict In-Stent Restenosis in Patients with Preserved Left Ventricular Function and Normal Troponin I Levels
   The American Journal of Cardiology. 2007 Apr 15;99(8):1051-4.
10. Comparison of Six-Month Angiographic and Three-Year Outcomes After Sirolimus-Eluting Stent Implantation Versus Brachytherapy for Bare Metal In-Stent Restenosis
    The American Journal of Cardiology. 2007 Aug 1;100(3):425-30.
11. Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) On Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent Implantation
    The American Journal of Cardiology. 2007 Aug 15;100(4):610-4.
12. Comparison of Virtual Histology to Intravascular Ultrasound of Culprit Coronary Lesions in Acute Coronary Syndrome and Target Coronary Lesions in Stable Angina Pectoris
    The American Journal of Cardiology. 2007 Sep 15;100(6):953-9.
13. Comparison of Triple Versus Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation (from the DECLARE-Long Trial)
    The American Journal of Cardiology. 2007 Oct 1;100(7):1103-8.
14. Relationship Between Peripheral Monocytosis and Nonrecovery of Left Ventricular Function in Patients with Left Ventricular Dysfunction Complicated with Acute Myocardial Infarction
    Circulation. 2007 Aug;71(8):1219-24.
15. Incidence and Predictors of Recurrent Restenosis Following Implantation of Drug-Eluting Stents for In-Stent Restenosis
    Catheterization and Cardiovascular Interventions. 2007 Jan;69(1):104-8.
16. Sirolimus-Eluting Stent Implantation for Treatment of Proximal Left Anterior Descending Coronary Artery Lesions: Long-Term Outcome and Predictors of Adverse Cardiac Events
    Catheterization and Cardiovascular Interventions. 2007 Sep;70(3):368-73.
17. Factors Predictive of Cardiac Events and Restenosis After Sirolimus-Eluting Stent Implantation in Small Coronary Arteries
    Catheterization and Cardiovascular Interventions. 2007 May 1;69(6):821-5.
18. Long-Term Outcome of Simultaneous Kissing Stenting Technique with Sirolimus-Eluting Stent for Large Bifurcation Coronary Lesions
    Catheterization and Cardiovascular Interventions. 2007 Nov 15;70(6):840-6.
19. Effect of Conventional Dose of Simvastatin on Plaque Regression and Vascular Remodeling in the Peristent Reference Segments of Normocholesterolemic Patients: A Serial Intravascular Ultrasound Assessment
    The Korean Circulation Journal. 2007 Oct;37(10):483-488.

2006

1. Late Stent Malapposition After Drug-Eluting Stent Implantation: An Intravascular Ultrasound Analysis with Long-Term Follow-Up
   Circulation. 2006 Jan 24;113(3):414-9.
2. Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients with Long Coronary Artery Disease
   Circulation. 2006 Nov 14;114(20):2148-53.
3. The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute Myocardial Infarction
   Journal of the American College of Cardiology. 2006 Mar 7;47(5):933-8.
4. Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation
   Journal of the American College of Cardiology. 2006 Dec 19;48(12):2432-9.
5. Intravascular Ultrasound Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation
   European Heart Journal. 2006 Jun;27(11):1305-10.
6. Predictors of Restenosis After Placement of Drug-Eluting Stents in One or More Coronary Arteries
   The American Journal of Cardiology. 2006 Feb 15;97(4):506-11.
7. Comparison of Simple and Complex Stenting Techniques in the Treatment of Unprotected Left Main Coronary Artery Bifurcation Stenosis
   The American Journal of Cardiology. 2006 Jun 1;97(11):1597-601.
8. Frequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-Up
   The American Journal of Cardiology. 2006 Aug 1;98(3):352-6.
9. Usefulness of Follow-Up Low-Density Lipoprotein Cholesterol Level as an Independent Predictor of Changes of Coronary Atherosclerotic Plaque Size as Determined by Intravascular Ultrasound Analysis After Statin (Atorvastatin or Simvastatin) Therapy
   The American Journal of Cardiology. 2006 Oct 1;98(7):866-70.
10. Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
    The American Journal of Cardiology. 2006 Oct 1;98(7):918-22.
11. Comparison with Conventional Therapies of Repeated Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting Coronary Stent Restenosis
    The American Journal of Cardiology. 2006 Dec 1;98(11):1451-4.
12. EuroSCORE as a Predictor of Death and Myocardial Infarction After Unprotected Left Main Coronary Stenting
    The American Journal of Cardiology. 2006 Dec 15;98(12):1567-70.
13. Effect of Combination Therapy with Simvastatin and Carvedilol in Patients with Left Ventricular Dysfunction Complicated with Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention
    Circulation. 2006 Oct;70(10):1269-74.
14. Clinical Significance of Aortic Knob Width and Calcification in Unstable Angina
    Circulation. 2006 Oct;70(10):1280-3.
15. Comparison of Sirolimus-Eluting Stent, Paclitaxel-Eluting Stent, and Bare Metal Stent in the Treatment of Long Coronary Lesions
    Catheterization and Cardiovascular Interventions. 2006 Feb;67(2):181-7.
16. Comparison of the Effectiveness of Sirolimus- and Paclitaxel-Eluting Stents for Small Coronary Artery Lesions
    Catheterization and Cardiovascular Interventions. 2006 Apr;67(4):589-94.
17. Safety and Efficacy with Drug-Eluting Stent in ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction
    Clinical Cardiology. 2006 May;29(5):199-203.
18. The Preventive Effect on In-Stent Restenosis of Overlapped Drug-Eluting Stents for Treating Diffuse Coronary Artery Disease
    The Korean Circulation Journal. 2006 Jan;36(1):17-23.
19. The Effect of Alpha Lipoic Acid (Thioctacid HR) on Endothelial Function in Diabetic and Hypertensive Patients
    The Korean Circulation Journal. 2006 Aug;36(8):559-564.
20. The Predictive Factor of Mortality and Prognosis of Cardiovascular Patients Admitted at Coronary Care Unit
    The Korean Journal of Medicine. 2006 Apr;70(4):386-392.
21. Incidence and Predictors of Late Recurrence After Beta-Radiation Therapy with a 188Re-MAG3-filled Balloon for Diffuse In-Stent Restenosis
    American Heart Journal. 2006 Jan;151(1):158-63.

2005

1. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis: Comparison with Bare Metal Stent Implantation
   Journal of the American College of Cardiology. 2005 Feb 1;45(3):351-6.
2. Triple Versus Dual Antiplatelet Therapy After Coronary Stenting: Impact on Stent Thrombosis
   Journal of the American College of Cardiology. 2005 Nov 15;46(10):1833-7.
3. The Site of Plaque Rupture in Native Coronary Arteries: A Three-Vessel Intravascular Ultrasound Analysis
   Journal of the American College of Cardiology. 2005 Jul 19;46(2):261-5.
4. Effectiveness of Sirolimus-Eluting Stent Implantation for the Treatment of Ostial Left Anterior Descending Artery Stenosis With Intravascular Ultrasound Guidance
   Journal of the American College of Cardiology. 2005 Sep 6;46(5):787-92.
5. Comparison of Quantitative Angiographic Parameters with the Magnitude of Neointimal Hyperplasia Measured by Volumetric Intravascular Ultrasound in Patients Treated with Bare Metal and Nonpolymeric Paclitaxel-Coated Stents
   The American Journal of Cardiology. 2005 Jan 1;95(1):105-7.
6. Intravascular Ultrasound Assessment of Neointima Distribution and the Length of Stent that was Free of Intravascular Ultrasound-Detectable Intimal Hyperplasia in Paclitaxel-Eluting Stents
   The American Journal of Cardiology. 2005 Jan 1;95(1):107-9.
7. Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents Era
   The American Journal of Cardiology. 2005 Nov 15;96(10):1389-92.
8. Long-Term Outcomes After Treatment of Diffuse In-Stent Restenosis with Rotational Atherectomy Followed by Beta-Radiation Therapy with a 188Re-MAG3-filled Balloon
   International Journal of Cardiology. 2005 Mar 18;99(2):201-5.
9. Comparison of Angiographic and Clinical Outcomes Between Rotational Atherectomy Versus Balloon Angioplasty Followed by Radiation Therapy with a Rhenium-188-Mercaptoacetyltriglycine-Filled Balloon in the Treatment of Diffuse In-Stent Restenosis
   International Journal of Cardiology. 2005 Jul 10;102(2):179-85.
10. Randomized Comparison of Carbon Ion-Implanted Stent Versus Bare Metal Stent in Coronary Artery Disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) Trial
    American Heart Journal. 2005 Feb;149(2):336-41.
11. Comparison of Angiographic and Clinical Outcomes Between Rotational Atherectomy and Cutting Balloon Angioplasty Followed by Radiation Therapy with a Rhenium 188-Mercaptoacetyltriglycine-Filled Balloon in the Treatment of Diffuse In-Stent Restenosis
    American Heart Journal. 2005 Sep;150(3):577-82.
12. Elevated Preprocedural High-Sensitivity C-Reactive Protein Levels are Associated with Neointimal Hyperplasia and Restenosis Development After Successful Coronary Artery Stenting
    Circulation. 2005 Dec;69(12):1477-83.
13. Two-Year Follow-Up Intravascular Ultrasound Analysis After Bare Metal Stent Implantation in 120 Lesions
    Catheterization and Cardiovascular Interventions. 2005 Jun;65(2):247-53.
14. The Long-Term Clinical Outcomes of Combination Therapy with Angiotensin II Type 1 Receptor Blocker and Simvastatin After Percutaneous Coronary Intervention
    The Korean Circulation Journal. 2005 Dec;35(12):877-882.

2004

1. Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent Implantation
   Circulation. 2004 Feb 24;109(7):881-6.
2. Comparison of Coronary Plaque Rupture Between Stable Angina and Acute Myocardial Infarction: A Three-Vessel Intravascular Ultrasound Study in 235 Patients
   Circulation. 2004 Aug 24;110(8):928-33.
3. Early and Late Clinical Outcomes After Primary Stenting of the Unprotected Left Main Coronary Artery Stenosis in the Setting of Acute Myocardial Infarction
   International Journal of Cardiology. 2004 Oct;97(1):73-6.
4. Change of Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction: A Study with Coronary Angiography
   American Heart Journal. 2004 Feb;147(2):281-6.
5. Randomized Comparison of Debulking Followed by Stenting Versus Stenting Alone for Ostial Left Anterior Descending Artery Stenosis: Intravascular Ultrasound Guidance
   American Heart Journal. 2004 Oct;148(4):663-9.
6. Late Intravascular Ultrasound Findings of Patients Treated with Brachytherapy for Diffuse In-Stent Restenosis
   Catheterization and Cardiovascular Interventions. 2004 Oct;63(2):208-14.
7. Bail-Out Stenting for Left Main Coronary Artery Dissection during Catheter-Based Procedure: Acute and Long-Term Results
   Clinical Cardiology. 2004 Jul;27(7):393-5.

2003

1. A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
   The New England Journal of Medicine. 2003 Apr 17;348(16):1537-45.
2. Paclitaxel Coating Reduces In-Stent Intimal Hyperplasia in Human Coronary Arteries: A Serial Volumetric Intravascular Ultrasound Analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)
   Circulation. 2003 Feb 4;107(4):517-20.
3. Impact of Preinterventional Arterial Remodeling on Neointimal Hyperplasia After Implantation of (Non-Polymer-Encapsulated) Paclitaxel-Coated Stents: A Serial Volumetric Intravascular Ultrasound Analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)
   Circulation. 2003 Sep 16;108(11):1295-8.
4. Extra-Stent Vascular Remodeling in In-Stent Restenosis After 188Re-MAG3 Radiation Therapy
   International Journal of Cardiology. 2003 Dec;92(2-3):187-91.
5. Intravascular Ultrasound Assessment of Patterns of Arterial Remodeling in the Absence of Significant Reference Segment Plaque Burden in Patients with Coronary Artery Disease
   Journal of the American College of Cardiology. 2003 Sep 3;42(5):806-10.